UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048185
Receipt number R000054055
Scientific Title Mathematical analysis of spatial and temporal changes in urticaria rash
Date of disclosure of the study information 2022/07/01
Last modified on 2023/06/29 22:51:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Mathematical analysis of spatial and temporal changes in urticaria rash

Acronym

Mathematical analysis of spatial and temporal changes in urticaria rash

Scientific Title

Mathematical analysis of spatial and temporal changes in urticaria rash

Scientific Title:Acronym

Mathematical analysis of spatial and temporal changes in urticaria rash

Region

Japan


Condition

Condition

urticaria

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In patients with chronic urticaria, the changes of wheals are photographed over time from their appearance to disappearance, and the morphological changes and morphological patterns of wheals are mathematically analyzed by using the obtained photographic data.

Basic objectives2

Others

Basic objectives -Others

Construction of mathematical model of urticaria rash

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Morphological changes and patterns

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Acquisition of photographic data of wheals over time.
Discontinuation of oral antihistamines for 3 days prior to study in some patients.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with chronic urticaria who visit the Department of Dermatology, Hiroshima University Hospital, and who meet all of the following selection criteria and none of the exclusion criteria will be eligible for the study.
(1) Patients who are at least 18 years old and not more than 85 years old at the time of obtaining consent.
(2) Patients who can provide written consent for participation in this study.
(3) Patients who have skin rashes almost every day even on treatment or who are expected to have skin rashes every day after discontinuation of treatment.

Key exclusion criteria

Patients deemed inappropriate by the principal investigator or research members

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Shunsuke
Middle name
Last name Takahagi

Organization

Hiroshima University Hospital

Division name

Dermatology

Zip code

734-8551

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8551

TEL

082-257-5555

Email

shunstk@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Daiki
Middle name
Last name Matsubara

Organization

Hiroshima University Hospital

Division name

Dermatology

Zip code

734-8551

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8551

TEL

082-257-5555

Homepage URL


Email

daiki523@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

CREST(Core Research for Evolutional Science and Technology)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8551

Tel

082-257-1947

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 06 Month 14 Day

Date of IRB

2022 Year 06 Month 16 Day

Anticipated trial start date

2022 Year 07 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

One case is currently included and under analysis.


Management information

Registered date

2022 Year 06 Month 28 Day

Last modified on

2023 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054055


Research Plan
Registered date File name
2023/06/29 蕁麻疹数理モデルの膨疹撮影研究_計画書ver1.1.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name